|
|
|
Corporate Profile: Cobalis
| Summary: |
| Cobalis’
current research is focused on studying the effects
of cyanocobalamin on the reduction of symptoms associated
with seasonal and perennial allergic rhinitis. Following
successful commercialization of cyanocobalmin, they
plan to sponsor clinical trials into other immunoglobulin-E
(IgE)-mediated allergic diseases. |
| Address: |
2030 Main Street
Suite 1300
Irvine, CA 92614
|
| Phone
#'s: |
| Main |
(949) 260-9007 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(949) 260-9002 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Internet
job postings: |
| not
known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
